nodes	percent_of_prediction	percent_of_DWPC	metapath
Telavancin—Extravasation—Goserelin—breast cancer	0.00865	0.00865	CcSEcCtD
Telavancin—Necrosis—Vinorelbine—breast cancer	0.00861	0.00861	CcSEcCtD
Telavancin—Venous thrombosis—Paclitaxel—breast cancer	0.00843	0.00843	CcSEcCtD
Telavancin—Ulcer—Melphalan—breast cancer	0.00818	0.00818	CcSEcCtD
Telavancin—Ulcer—Goserelin—breast cancer	0.00798	0.00798	CcSEcCtD
Telavancin—Extravasation—Vinorelbine—breast cancer	0.00775	0.00775	CcSEcCtD
Telavancin—Extravasation—Thiotepa—breast cancer	0.0074	0.0074	CcSEcCtD
Telavancin—Necrosis—Mitoxantrone—breast cancer	0.00711	0.00711	CcSEcCtD
Telavancin—Venous thrombosis—Capecitabine—breast cancer	0.00691	0.00691	CcSEcCtD
Telavancin—Phlebitis—Vinblastine—breast cancer	0.00686	0.00686	CcSEcCtD
Telavancin—Necrosis—Fluorouracil—breast cancer	0.0068	0.0068	CcSEcCtD
Telavancin—Extravasation—Mitoxantrone—breast cancer	0.00639	0.00639	CcSEcCtD
Telavancin—Extravasation—Irinotecan—breast cancer	0.00639	0.00639	CcSEcCtD
Telavancin—Extravasation—Gemcitabine—breast cancer	0.00623	0.00623	CcSEcCtD
Telavancin—Tenderness—Gemcitabine—breast cancer	0.00623	0.00623	CcSEcCtD
Telavancin—Extravasation—Fluorouracil—breast cancer	0.00612	0.00612	CcSEcCtD
Telavancin—Tenderness—Fluorouracil—breast cancer	0.00612	0.00612	CcSEcCtD
Telavancin—Infection—Carboplatin—breast cancer	0.00612	0.00612	CcSEcCtD
Telavancin—Ulcer—Irinotecan—breast cancer	0.0059	0.0059	CcSEcCtD
Telavancin—Ulcer—Mitoxantrone—breast cancer	0.0059	0.0059	CcSEcCtD
Telavancin—Necrosis—Paclitaxel—breast cancer	0.00579	0.00579	CcSEcCtD
Telavancin—Infection—Lapatinib—breast cancer	0.00577	0.00577	CcSEcCtD
Telavancin—Ulcer—Gemcitabine—breast cancer	0.00574	0.00574	CcSEcCtD
Telavancin—Phlebitis—Vinorelbine—breast cancer	0.0057	0.0057	CcSEcCtD
Telavancin—Ulcer—Fluorouracil—breast cancer	0.00565	0.00565	CcSEcCtD
Telavancin—Hyponatraemia—Melphalan—breast cancer	0.00564	0.00564	CcSEcCtD
Telavancin—Hyperkalaemia—Mitoxantrone—breast cancer	0.00548	0.00548	CcSEcCtD
Telavancin—Infection—Fulvestrant—breast cancer	0.0053	0.0053	CcSEcCtD
Telavancin—Tenderness—Paclitaxel—breast cancer	0.00521	0.00521	CcSEcCtD
Telavancin—Extravasation—Paclitaxel—breast cancer	0.00521	0.00521	CcSEcCtD
Telavancin—Hyponatraemia—Vinorelbine—breast cancer	0.00493	0.00493	CcSEcCtD
Telavancin—Necrosis—Docetaxel—breast cancer	0.00491	0.00491	CcSEcCtD
Telavancin—Body temperature increased—Carboplatin—breast cancer	0.00487	0.00487	CcSEcCtD
Telavancin—Nausea—Fluoxymesterone—breast cancer	0.00486	0.00486	CcSEcCtD
Telavancin—Venous thrombosis—Epirubicin—breast cancer	0.00482	0.00482	CcSEcCtD
Telavancin—Abdominal discomfort—Tamoxifen—breast cancer	0.00475	0.00475	CcSEcCtD
Telavancin—Flatulence—Raloxifene—breast cancer	0.00472	0.00472	CcSEcCtD
Telavancin—Phlebitis—Mitoxantrone—breast cancer	0.0047	0.0047	CcSEcCtD
Telavancin—Infection—Exemestane—breast cancer	0.00461	0.00461	CcSEcCtD
Telavancin—Venous thrombosis—Doxorubicin—breast cancer	0.00446	0.00446	CcSEcCtD
Telavancin—Extravasation—Docetaxel—breast cancer	0.00442	0.00442	CcSEcCtD
Telavancin—Infection—Ixabepilone—breast cancer	0.00435	0.00435	CcSEcCtD
Telavancin—Body temperature increased—Fulvestrant—breast cancer	0.00422	0.00422	CcSEcCtD
Telavancin—Infection—Letrozole—breast cancer	0.00409	0.00409	CcSEcCtD
Telavancin—Infection—Anastrozole—breast cancer	0.00409	0.00409	CcSEcCtD
Telavancin—Hyponatraemia—Mitoxantrone—breast cancer	0.00406	0.00406	CcSEcCtD
Telavancin—Hyponatraemia—Irinotecan—breast cancer	0.00406	0.00406	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Mitoxantrone—breast cancer	0.00405	0.00405	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Irinotecan—breast cancer	0.00405	0.00405	CcSEcCtD
Telavancin—Diarrhoea—Lapatinib—breast cancer	0.00397	0.00397	CcSEcCtD
Telavancin—Ulcer—Capecitabine—breast cancer	0.00395	0.00395	CcSEcCtD
Telavancin—Infection—Raloxifene—breast cancer	0.00389	0.00389	CcSEcCtD
Telavancin—Infection—Idarubicin—breast cancer	0.00389	0.00389	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Fluorouracil—breast cancer	0.00388	0.00388	CcSEcCtD
Telavancin—Phlebitis—Paclitaxel—breast cancer	0.00383	0.00383	CcSEcCtD
Telavancin—Vomiting—Lapatinib—breast cancer	0.00369	0.00369	CcSEcCtD
Telavancin—Body temperature increased—Exemestane—breast cancer	0.00367	0.00367	CcSEcCtD
Telavancin—Rash—Lapatinib—breast cancer	0.00366	0.00366	CcSEcCtD
Telavancin—Dermatitis—Lapatinib—breast cancer	0.00366	0.00366	CcSEcCtD
Telavancin—Diarrhoea—Fulvestrant—breast cancer	0.00365	0.00365	CcSEcCtD
Telavancin—Necrosis—Methotrexate—breast cancer	0.00354	0.00354	CcSEcCtD
Telavancin—Abscess—Methotrexate—breast cancer	0.00351	0.00351	CcSEcCtD
Telavancin—Body temperature increased—Ixabepilone—breast cancer	0.00346	0.00346	CcSEcCtD
Telavancin—Nausea—Lapatinib—breast cancer	0.00345	0.00345	CcSEcCtD
Telavancin—Vomiting—Fulvestrant—breast cancer	0.0034	0.0034	CcSEcCtD
Telavancin—Rash—Fulvestrant—breast cancer	0.00337	0.00337	CcSEcCtD
Telavancin—Dermatitis—Fulvestrant—breast cancer	0.00336	0.00336	CcSEcCtD
Telavancin—Vomiting—Toremifene—breast cancer	0.00335	0.00335	CcSEcCtD
Telavancin—Rash—Toremifene—breast cancer	0.00332	0.00332	CcSEcCtD
Telavancin—Dermatitis—Toremifene—breast cancer	0.00332	0.00332	CcSEcCtD
Telavancin—Hyponatraemia—Paclitaxel—breast cancer	0.00331	0.00331	CcSEcCtD
Telavancin—Necrosis—Epirubicin—breast cancer	0.00331	0.00331	CcSEcCtD
Telavancin—Abscess—Epirubicin—breast cancer	0.00329	0.00329	CcSEcCtD
Telavancin—Body temperature increased—Anastrozole—breast cancer	0.00326	0.00326	CcSEcCtD
Telavancin—Body temperature increased—Letrozole—breast cancer	0.00326	0.00326	CcSEcCtD
Telavancin—Flatulence—Goserelin—breast cancer	0.00325	0.00325	CcSEcCtD
Telavancin—Phlebitis—Docetaxel—breast cancer	0.00325	0.00325	CcSEcCtD
Telavancin—Extravasation—Methotrexate—breast cancer	0.00318	0.00318	CcSEcCtD
Telavancin—Diarrhoea—Exemestane—breast cancer	0.00317	0.00317	CcSEcCtD
Telavancin—Nausea—Fulvestrant—breast cancer	0.00317	0.00317	CcSEcCtD
Telavancin—Infection—Chlorambucil—breast cancer	0.00315	0.00315	CcSEcCtD
Telavancin—Phlebitis—Capecitabine—breast cancer	0.00314	0.00314	CcSEcCtD
Telavancin—Nausea—Toremifene—breast cancer	0.00313	0.00313	CcSEcCtD
Telavancin—Body temperature increased—Idarubicin—breast cancer	0.00309	0.00309	CcSEcCtD
Telavancin—Body temperature increased—Raloxifene—breast cancer	0.00309	0.00309	CcSEcCtD
Telavancin—Necrosis—Doxorubicin—breast cancer	0.00307	0.00307	CcSEcCtD
Telavancin—Abscess—Doxorubicin—breast cancer	0.00304	0.00304	CcSEcCtD
Telavancin—Diarrhoea—Ixabepilone—breast cancer	0.00299	0.00299	CcSEcCtD
Telavancin—Extravasation—Epirubicin—breast cancer	0.00298	0.00298	CcSEcCtD
Telavancin—Vomiting—Exemestane—breast cancer	0.00295	0.00295	CcSEcCtD
Telavancin—Ulcer—Methotrexate—breast cancer	0.00294	0.00294	CcSEcCtD
Telavancin—Rash—Exemestane—breast cancer	0.00292	0.00292	CcSEcCtD
Telavancin—Dermatitis—Exemestane—breast cancer	0.00292	0.00292	CcSEcCtD
Telavancin—Diarrhoea—Anastrozole—breast cancer	0.00282	0.00282	CcSEcCtD
Telavancin—Diarrhoea—Letrozole—breast cancer	0.00282	0.00282	CcSEcCtD
Telavancin—Hyponatraemia—Docetaxel—breast cancer	0.00281	0.00281	CcSEcCtD
Telavancin—Infection—Tamoxifen—breast cancer	0.0028	0.0028	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Docetaxel—breast cancer	0.0028	0.0028	CcSEcCtD
Telavancin—Vomiting—Ixabepilone—breast cancer	0.00278	0.00278	CcSEcCtD
Telavancin—Rash—Ixabepilone—breast cancer	0.00276	0.00276	CcSEcCtD
Telavancin—Extravasation—Doxorubicin—breast cancer	0.00276	0.00276	CcSEcCtD
Telavancin—Dermatitis—Ixabepilone—breast cancer	0.00276	0.00276	CcSEcCtD
Telavancin—Nausea—Exemestane—breast cancer	0.00275	0.00275	CcSEcCtD
Telavancin—Ulcer—Epirubicin—breast cancer	0.00275	0.00275	CcSEcCtD
Telavancin—Infection—Melphalan—breast cancer	0.00274	0.00274	CcSEcCtD
Telavancin—Hyponatraemia—Capecitabine—breast cancer	0.00272	0.00272	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Capecitabine—breast cancer	0.00271	0.00271	CcSEcCtD
Telavancin—Diarrhoea—Raloxifene—breast cancer	0.00268	0.00268	CcSEcCtD
Telavancin—Diarrhoea—Idarubicin—breast cancer	0.00268	0.00268	CcSEcCtD
Telavancin—Infection—Goserelin—breast cancer	0.00268	0.00268	CcSEcCtD
Telavancin—Vomiting—Anastrozole—breast cancer	0.00262	0.00262	CcSEcCtD
Telavancin—Vomiting—Letrozole—breast cancer	0.00262	0.00262	CcSEcCtD
Telavancin—Nausea—Ixabepilone—breast cancer	0.0026	0.0026	CcSEcCtD
Telavancin—Rash—Letrozole—breast cancer	0.0026	0.0026	CcSEcCtD
Telavancin—Rash—Anastrozole—breast cancer	0.0026	0.0026	CcSEcCtD
Telavancin—Dermatitis—Anastrozole—breast cancer	0.0026	0.0026	CcSEcCtD
Telavancin—Dermatitis—Letrozole—breast cancer	0.0026	0.0026	CcSEcCtD
Telavancin—Hyperkalaemia—Epirubicin—breast cancer	0.00255	0.00255	CcSEcCtD
Telavancin—Ulcer—Doxorubicin—breast cancer	0.00254	0.00254	CcSEcCtD
Telavancin—Body temperature increased—Chlorambucil—breast cancer	0.0025	0.0025	CcSEcCtD
Telavancin—Vomiting—Idarubicin—breast cancer	0.00249	0.00249	CcSEcCtD
Telavancin—Vomiting—Raloxifene—breast cancer	0.00249	0.00249	CcSEcCtD
Telavancin—Rash—Idarubicin—breast cancer	0.00247	0.00247	CcSEcCtD
Telavancin—Rash—Raloxifene—breast cancer	0.00247	0.00247	CcSEcCtD
Telavancin—Dermatitis—Idarubicin—breast cancer	0.00246	0.00246	CcSEcCtD
Telavancin—Dermatitis—Raloxifene—breast cancer	0.00246	0.00246	CcSEcCtD
Telavancin—Nausea—Anastrozole—breast cancer	0.00245	0.00245	CcSEcCtD
Telavancin—Nausea—Letrozole—breast cancer	0.00245	0.00245	CcSEcCtD
Telavancin—Flatulence—Irinotecan—breast cancer	0.0024	0.0024	CcSEcCtD
Telavancin—Infection—Vinorelbine—breast cancer	0.0024	0.0024	CcSEcCtD
Telavancin—Hyperkalaemia—Doxorubicin—breast cancer	0.00236	0.00236	CcSEcCtD
Telavancin—Nausea—Idarubicin—breast cancer	0.00232	0.00232	CcSEcCtD
Telavancin—Nausea—Raloxifene—breast cancer	0.00232	0.00232	CcSEcCtD
Telavancin—Infection—Thiotepa—breast cancer	0.00229	0.00229	CcSEcCtD
Telavancin—Abdominal discomfort—Capecitabine—breast cancer	0.00224	0.00224	CcSEcCtD
Telavancin—Phlebitis—Epirubicin—breast cancer	0.00219	0.00219	CcSEcCtD
Telavancin—Diarrhoea—Chlorambucil—breast cancer	0.00217	0.00217	CcSEcCtD
Telavancin—Body temperature increased—Goserelin—breast cancer	0.00213	0.00213	CcSEcCtD
Telavancin—Phlebitis—Doxorubicin—breast cancer	0.00203	0.00203	CcSEcCtD
Telavancin—Vomiting—Chlorambucil—breast cancer	0.00201	0.00201	CcSEcCtD
Telavancin—Diarrhoea—Vinblastine—breast cancer	0.00199	0.00199	CcSEcCtD
Telavancin—Infection—Mitoxantrone—breast cancer	0.00198	0.00198	CcSEcCtD
Telavancin—Infection—Irinotecan—breast cancer	0.00198	0.00198	CcSEcCtD
Telavancin—Flatulence—Paclitaxel—breast cancer	0.00196	0.00196	CcSEcCtD
Telavancin—Diarrhoea—Tamoxifen—breast cancer	0.00193	0.00193	CcSEcCtD
Telavancin—Infection—Gemcitabine—breast cancer	0.00193	0.00193	CcSEcCtD
Telavancin—Body temperature increased—Vinorelbine—breast cancer	0.00191	0.00191	CcSEcCtD
Telavancin—Hyponatraemia—Epirubicin—breast cancer	0.0019	0.0019	CcSEcCtD
Telavancin—Infection—Fluorouracil—breast cancer	0.00189	0.00189	CcSEcCtD
Telavancin—Diarrhoea—Melphalan—breast cancer	0.00189	0.00189	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Epirubicin—breast cancer	0.00189	0.00189	CcSEcCtD
Telavancin—Nausea—Chlorambucil—breast cancer	0.00188	0.00188	CcSEcCtD
Telavancin—Vomiting—Vinblastine—breast cancer	0.00185	0.00185	CcSEcCtD
Telavancin—Diarrhoea—Goserelin—breast cancer	0.00184	0.00184	CcSEcCtD
Telavancin—Body temperature increased—Thiotepa—breast cancer	0.00182	0.00182	CcSEcCtD
Telavancin—Vomiting—Tamoxifen—breast cancer	0.00179	0.00179	CcSEcCtD
Telavancin—Rash—Tamoxifen—breast cancer	0.00178	0.00178	CcSEcCtD
Telavancin—Dermatitis—Tamoxifen—breast cancer	0.00178	0.00178	CcSEcCtD
Telavancin—Vomiting—Melphalan—breast cancer	0.00176	0.00176	CcSEcCtD
Telavancin—Hyponatraemia—Doxorubicin—breast cancer	0.00175	0.00175	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Doxorubicin—breast cancer	0.00175	0.00175	CcSEcCtD
Telavancin—Rash—Melphalan—breast cancer	0.00174	0.00174	CcSEcCtD
Telavancin—Dermatitis—Melphalan—breast cancer	0.00174	0.00174	CcSEcCtD
Telavancin—Nausea—Vinblastine—breast cancer	0.00172	0.00172	CcSEcCtD
Telavancin—Vomiting—Goserelin—breast cancer	0.00171	0.00171	CcSEcCtD
Telavancin—Rash—Goserelin—breast cancer	0.0017	0.0017	CcSEcCtD
Telavancin—Dermatitis—Goserelin—breast cancer	0.0017	0.0017	CcSEcCtD
Telavancin—Nausea—Tamoxifen—breast cancer	0.00168	0.00168	CcSEcCtD
Telavancin—Abdominal discomfort—Methotrexate—breast cancer	0.00167	0.00167	CcSEcCtD
Telavancin—Diarrhoea—Vinorelbine—breast cancer	0.00165	0.00165	CcSEcCtD
Telavancin—Nausea—Melphalan—breast cancer	0.00164	0.00164	CcSEcCtD
Telavancin—Infection—Paclitaxel—breast cancer	0.00161	0.00161	CcSEcCtD
Telavancin—Flatulence—Capecitabine—breast cancer	0.00161	0.00161	CcSEcCtD
Telavancin—Nausea—Goserelin—breast cancer	0.0016	0.0016	CcSEcCtD
Telavancin—Diarrhoea—Thiotepa—breast cancer	0.00158	0.00158	CcSEcCtD
Telavancin—Body temperature increased—Mitoxantrone—breast cancer	0.00157	0.00157	CcSEcCtD
Telavancin—Body temperature increased—Irinotecan—breast cancer	0.00157	0.00157	CcSEcCtD
Telavancin—Vomiting—Vinorelbine—breast cancer	0.00153	0.00153	CcSEcCtD
Telavancin—Body temperature increased—Gemcitabine—breast cancer	0.00153	0.00153	CcSEcCtD
Telavancin—Rash—Vinorelbine—breast cancer	0.00152	0.00152	CcSEcCtD
Telavancin—Dermatitis—Vinorelbine—breast cancer	0.00152	0.00152	CcSEcCtD
Telavancin—Body temperature increased—Fluorouracil—breast cancer	0.00151	0.00151	CcSEcCtD
Telavancin—Vomiting—Thiotepa—breast cancer	0.00146	0.00146	CcSEcCtD
Telavancin—Rash—Thiotepa—breast cancer	0.00145	0.00145	CcSEcCtD
Telavancin—Dermatitis—Thiotepa—breast cancer	0.00145	0.00145	CcSEcCtD
Telavancin—Nausea—Vinorelbine—breast cancer	0.00143	0.00143	CcSEcCtD
Telavancin—Nausea—Thiotepa—breast cancer	0.00137	0.00137	CcSEcCtD
Telavancin—Infection—Docetaxel—breast cancer	0.00137	0.00137	CcSEcCtD
Telavancin—Diarrhoea—Irinotecan—breast cancer	0.00136	0.00136	CcSEcCtD
Telavancin—Diarrhoea—Mitoxantrone—breast cancer	0.00136	0.00136	CcSEcCtD
Telavancin—Diarrhoea—Gemcitabine—breast cancer	0.00133	0.00133	CcSEcCtD
Telavancin—Infection—Capecitabine—breast cancer	0.00132	0.00132	CcSEcCtD
Telavancin—Diarrhoea—Fluorouracil—breast cancer	0.0013	0.0013	CcSEcCtD
Telavancin—Body temperature increased—Paclitaxel—breast cancer	0.00128	0.00128	CcSEcCtD
Telavancin—Vomiting—Mitoxantrone—breast cancer	0.00127	0.00127	CcSEcCtD
Telavancin—Vomiting—Irinotecan—breast cancer	0.00127	0.00127	CcSEcCtD
Telavancin—Rash—Irinotecan—breast cancer	0.00125	0.00125	CcSEcCtD
Telavancin—Rash—Mitoxantrone—breast cancer	0.00125	0.00125	CcSEcCtD
Telavancin—Dermatitis—Mitoxantrone—breast cancer	0.00125	0.00125	CcSEcCtD
Telavancin—Dermatitis—Irinotecan—breast cancer	0.00125	0.00125	CcSEcCtD
Telavancin—Vomiting—Gemcitabine—breast cancer	0.00123	0.00123	CcSEcCtD
Telavancin—Rash—Gemcitabine—breast cancer	0.00122	0.00122	CcSEcCtD
Telavancin—Dermatitis—Gemcitabine—breast cancer	0.00122	0.00122	CcSEcCtD
Telavancin—Vomiting—Fluorouracil—breast cancer	0.00121	0.00121	CcSEcCtD
Telavancin—Rash—Fluorouracil—breast cancer	0.0012	0.0012	CcSEcCtD
Telavancin—Dermatitis—Fluorouracil—breast cancer	0.0012	0.0012	CcSEcCtD
Telavancin—Nausea—Irinotecan—breast cancer	0.00118	0.00118	CcSEcCtD
Telavancin—Nausea—Mitoxantrone—breast cancer	0.00118	0.00118	CcSEcCtD
Telavancin—Nausea—Gemcitabine—breast cancer	0.00115	0.00115	CcSEcCtD
Telavancin—Nausea—Fluorouracil—breast cancer	0.00113	0.00113	CcSEcCtD
Telavancin—Flatulence—Epirubicin—breast cancer	0.00112	0.00112	CcSEcCtD
Telavancin—Diarrhoea—Paclitaxel—breast cancer	0.00111	0.00111	CcSEcCtD
Telavancin—Body temperature increased—Docetaxel—breast cancer	0.00109	0.00109	CcSEcCtD
Telavancin—Body temperature increased—Capecitabine—breast cancer	0.00105	0.00105	CcSEcCtD
Telavancin—Flatulence—Doxorubicin—breast cancer	0.00104	0.00104	CcSEcCtD
Telavancin—Vomiting—Paclitaxel—breast cancer	0.00103	0.00103	CcSEcCtD
Telavancin—Rash—Paclitaxel—breast cancer	0.00102	0.00102	CcSEcCtD
Telavancin—Dermatitis—Paclitaxel—breast cancer	0.00102	0.00102	CcSEcCtD
Telavancin—Infection—Methotrexate—breast cancer	0.000985	0.000985	CcSEcCtD
Telavancin—Nausea—Paclitaxel—breast cancer	0.000964	0.000964	CcSEcCtD
Telavancin—Diarrhoea—Docetaxel—breast cancer	0.000941	0.000941	CcSEcCtD
Telavancin—Infection—Epirubicin—breast cancer	0.000922	0.000922	CcSEcCtD
Telavancin—Diarrhoea—Capecitabine—breast cancer	0.000911	0.000911	CcSEcCtD
Telavancin—Vomiting—Docetaxel—breast cancer	0.000874	0.000874	CcSEcCtD
Telavancin—Rash—Docetaxel—breast cancer	0.000867	0.000867	CcSEcCtD
Telavancin—Dermatitis—Docetaxel—breast cancer	0.000866	0.000866	CcSEcCtD
Telavancin—Infection—Doxorubicin—breast cancer	0.000853	0.000853	CcSEcCtD
Telavancin—Vomiting—Capecitabine—breast cancer	0.000847	0.000847	CcSEcCtD
Telavancin—Rash—Capecitabine—breast cancer	0.00084	0.00084	CcSEcCtD
Telavancin—Dermatitis—Capecitabine—breast cancer	0.000839	0.000839	CcSEcCtD
Telavancin—Nausea—Docetaxel—breast cancer	0.000817	0.000817	CcSEcCtD
Telavancin—Nausea—Capecitabine—breast cancer	0.000791	0.000791	CcSEcCtD
Telavancin—Body temperature increased—Methotrexate—breast cancer	0.000784	0.000784	CcSEcCtD
Telavancin—Body temperature increased—Epirubicin—breast cancer	0.000733	0.000733	CcSEcCtD
Telavancin—Body temperature increased—Doxorubicin—breast cancer	0.000679	0.000679	CcSEcCtD
Telavancin—Diarrhoea—Methotrexate—breast cancer	0.000678	0.000678	CcSEcCtD
Telavancin—Diarrhoea—Epirubicin—breast cancer	0.000635	0.000635	CcSEcCtD
Telavancin—Vomiting—Methotrexate—breast cancer	0.00063	0.00063	CcSEcCtD
Telavancin—Rash—Methotrexate—breast cancer	0.000625	0.000625	CcSEcCtD
Telavancin—Dermatitis—Methotrexate—breast cancer	0.000624	0.000624	CcSEcCtD
Telavancin—Vomiting—Epirubicin—breast cancer	0.00059	0.00059	CcSEcCtD
Telavancin—Nausea—Methotrexate—breast cancer	0.000589	0.000589	CcSEcCtD
Telavancin—Diarrhoea—Doxorubicin—breast cancer	0.000587	0.000587	CcSEcCtD
Telavancin—Rash—Epirubicin—breast cancer	0.000585	0.000585	CcSEcCtD
Telavancin—Dermatitis—Epirubicin—breast cancer	0.000584	0.000584	CcSEcCtD
Telavancin—Nausea—Epirubicin—breast cancer	0.000551	0.000551	CcSEcCtD
Telavancin—Vomiting—Doxorubicin—breast cancer	0.000546	0.000546	CcSEcCtD
Telavancin—Rash—Doxorubicin—breast cancer	0.000541	0.000541	CcSEcCtD
Telavancin—Dermatitis—Doxorubicin—breast cancer	0.000541	0.000541	CcSEcCtD
Telavancin—Nausea—Doxorubicin—breast cancer	0.00051	0.00051	CcSEcCtD
